DYNLL2 Antibodies

Santa Cruz Biotechnology delivers a wide array of DYNLL2 monoclonal antibodies for research focused on understanding DYNLL2 protein functions. DYNLL2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DYNLL2, also known as dynein light chain 2, functions as a key component of the dynein motor complex, participating in intracellular transport and organelle movement. DYNLL2 drives essential cellular processes including mitosis, endocytosis, and maintenance of cellular architecture. Research has shown DYNLL2's significance in multiple biological pathways, making it a focal point for understanding various diseases, particularly neurodegenerative disorders and cancer. Investigating DYNLL2 continues to reveal new insights about cellular transport mechanisms and their impact on health and disease. Researchers worldwide rely on high-quality tools to advance their understanding of cellular dynamics and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers to conduct precise studies that contribute to advancing scientific knowledge and therapeutic development.